Oxidative stress in the metabolic syndrome

被引:73
作者
Esposito, K.
Ciotola, M.
Schisano, B.
Misso, L.
Giannetti, G.
Ceriello, A.
Gugliano, D.
机构
[1] Univ Naples SUN, Div Metab Dis, Dept Geriatr & Metab Dis, Naples, Italy
[2] Warwick Med Sch, Coventry, W Midlands, England
关键词
metabolic syndrome; nitrotyrosine; endothelium-dependent vasocilation; insulin resistance;
D O I
10.1007/BF03347372
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The metabolic syndrome represents a cluster of several risk factors for atherosclerosis that increases the risk of future cardiovascular events. In this study, we evaluated whether oxidative stress is increased in subjects with the metabolic syndrome. We studied 100 subjects (50 men and 50 women) with the metabolic syndrome, as defined by the Adult Treatment Panel III, and 50 (25 men and 25 women) matched subjects without the syndrome. Insulin sensitivity was assessed with the homeostasis model assessment (HOMA) methods; endothelium-dependent flow-mediated vasodilation (FMD) was evaluated in the right brachial artery with a high-resolution ultrasound machine; oxidative stress was assessed by measuring the circulating levels of nitrotyrosine (NT), considered a good marker for the formation of endogenous peroxynitrite. Compared with control subjects, patients with the metabolic syndrome had greater waist circumference, higher HOMA and systolic pressure values, higher triglyceride and lower HDL-cholesterol levels. NT levels were higher (0.44 +/- 0.12 mu mol/l, mean +/- SD) while FMD was lower [7.3 (4.4/9.6), median and interquartile range] in subjects with the metabolic syndrome as compared with control subjects [0.27 +/- 0.08 and 11.8 (8.6/14.9), respectively, p < 0.001]. There was an increase in NT levels and HOMA score as the number of components of the metabolic syndrome increased. NT levels were associated with waist circumference (r=0.38, p=0.01), triglycerides (r=0.32, p < 0.02), systolic blood pressure (r=0.21, p < 0.05) and fasting glucose (r=0.24, p < 0.05). The oxidative stress that accompanies the metabolic syndrome is associated with both insulin resistance and endothelial dysfunction, providing a connection which is highly deleterious for vascular functions.
引用
收藏
页码:791 / 795
页数:5
相关论文
共 32 条
[1]
Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
[2]
Endothelial dysfunction in cardiovascular diseases - The role of oxidant stress [J].
Cai, H ;
Harrison, DG .
CIRCULATION RESEARCH, 2000, 87 (10) :840-844
[3]
Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited [J].
Ceriello, A ;
Motz, E .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) :816-823
[4]
Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat [J].
Ceriello, A ;
Quagliaro, L ;
D'Amico, M ;
Di Filippo, C ;
Marfella, R ;
Nappo, F ;
Berrino, L ;
Rossi, F ;
Giugliano, D .
DIABETES, 2002, 51 (04) :1076-1082
[5]
Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation - Effects of short- and long-term simvastatin treatment [J].
Ceriello, A ;
Taboga, C ;
Tonutti, L ;
Quagliaro, L ;
Piconi, L ;
Bais, B ;
Da Ros, R ;
Motz, E .
CIRCULATION, 2002, 106 (10) :1211-1218
[6]
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[7]
Diabetes and vascular disease -: Pathophysiology, clinical consequences, and medical therapy:: Part I [J].
Creager, MA ;
Lüscher, TF ;
Cosentino, F ;
Beckman, JA .
CIRCULATION, 2003, 108 (12) :1527-1532
[8]
Cuzzocrea S, 2001, PHARMACOL REV, V53, P135
[9]
Metabolic syndrome - A comprehensive perspective based on interactions between obesity, diabetes, and inflammation [J].
Dandona, P ;
Aljada, A ;
Chaudhuri, A ;
Mohanty, P ;
Garg, R .
CIRCULATION, 2005, 111 (11) :1448-1454
[10]
The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm [J].
Dandona, P ;
Aljada, A ;
Mohanty, P .
DIABETOLOGIA, 2002, 45 (06) :924-930